Irrespective of subsets, we also found that all γδ T cells from patients with melanoma and independent of ICB outcome had a significant reduction in the expression of a number of genes coding AP-1 transcription factors, which are important in augmenting TCR and co-stimulation driven T cell activation (Atsaves et al, 2019). The gene discussed is FOS; the disease is melanoma.